Concepedia

Kathlyn Lim

KL

8

Publications

353

Citations

8

H-Index

2019

Active since

Affiliations

Cedars-Sinai Medical Center(Current)

Kathlyn Lim is an author at Cedars-Sinai Medical Center specializing in renal pathology, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2019–2022

8

Publications

8

Obinutuzumab is Effective for the Treatment of Refractory Membranous Nephropathy

Supreet Sethi, Sanjeev Kumar, Kathlyn Lim et al. · Kidney International Reports · 2020 · 94 citations · Full text

, , +25

Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

Edmund Huang, Ashley Vo, Jua Choi et al. · Clinical Journal of the American Society of Nephrology · 2019 · 63 citations · Full text

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts

Stanley C. Jordan, Noriko Ammerman, Jua Choi et al. · Kidney International Reports · 2022 · 52 citations · Full text

The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection

Stanley C. Jordan, Noriko Ammerman, Jua Choi et al. · American Journal of Transplantation · 2020 · 43 citations · Full text

Clazakizumab for desensitization in highly sensitized patients awaiting transplantation

Ashley Vo, Edmund Huang, Noriko Ammerman et al. · American Journal of Transplantation · 2021 · 41 citations

Rows per page

1–5 of 8